Related Experiment Video

Updated: Jan 26, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

7.9K

Hepatitis C virus ultrastructure and morphogenesis

Philippe Roingeard1, Christophe Hourioux, Emmanuelle Blanchard

  • 1Laboratoire de Biologie Cellulaire et Laboratoire de Virologie, Faculté de Médecine ed Centre Hospitalier Universitaire, Tours, France. roingeard@med.univ-tours.fr

Biology of the Cell
|May 1, 2004
PubMed

Insights

Hepatitis C virus (HCV) morphogenesis is challenging to study. Virus-like particles (VLPs) reveal that HCV budding occurs at the ER membrane, driven by the core protein, aiding future research.

Area of Science:

  • Virology
  • Cell Biology
  • Hepatitis C Research

Background:

  • Ultrastructural details of Hepatitis C virus (HCV) virions are poorly understood due to visualization difficulties in infected tissues.
  • Limited knowledge exists regarding HCV morphogenesis, primarily because of the absence of an efficient in vitro propagation system.

Purpose of the Study:

  • To investigate Hepatitis C virus (HCV) morphogenesis using an alternative model system.
  • To elucidate the mechanisms of HCV particle assembly and budding.

Main Methods:

  • Generation of Hepatitis C virus-like particles (HCV-LPs) by expressing HCV structural proteins in mammalian cells.
  • Utilizing the HCV-LP model to study viral morphogenesis and protein-driven processes.

Main Results:

  • The HCV-LP model successfully demonstrated that HCV budding initiates at the endoplasmic reticulum (ER) membrane.
  • The core protein was identified as the driving force behind the HCV budding process.

Conclusions:

  • The HCV-LP model provides a valuable tool for studying viral morphogenesis and virus-host interactions.
  • This model offers new avenues for developing an in vitro culture system for Hepatitis C virus (HCV).

More Related Videos

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

13.9K
A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.7K

Related Concept Videos

Morphogenesis02:19

Morphogenesis

Plant morphogenesis—the development of a plant’s form and structure—involves several overlapping developmental processes, including growth and cell differentiation. Precursor cells differentiate into specific cell types, which are organized into the tissues and organ systems that make up the functional plant.
30.4K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
221
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
266
What are Viruses?00:50

What are Viruses?

Overview
127.9K
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.6K
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
543